Safinamide mesylate
Drug ingredientCAS 202825-46-5
This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
US productionNot reported
Top sourceNo public record
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownWhere It Comes From
EPA and Census publish no US supply data for this chemical.
7 FDA-registered drug labelers
Apicore Pharmaceuticals Private Limited
Aurobindo Pharma Limited
Biophore India Pharmaceuticals Private Limited
HONOUR LAB LIMITED
MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.
MSN Life Sciences Private Limited
Optimus Drugs Private Limited
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Xadago
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS202825-46-5
PubChem CID3038502
DTXSIDDTXSID80942414
FormulaC18H23FN2O5S
Mol. Weight398.5 g/mol
SMILESCC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F.CS(=O)(=O)O
Data Sources
- PubChem · compound 3038502Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA National Drug Code directoryRetrieved 2026-04-07
Brief citations
Safinamide mesylate (CAS 202825-46-5) https://chemicalindependence.com/chemical/202825-46-5/ PubChem: 3038502. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/3038502 FDA National Drug Code directory: CAS 202825-46-5. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/